Literature DB >> 23957472

Atmospheric pressure, nonthermal plasma inactivation of MS2 bacteriophage: effect of oxygen concentration on virucidal activity.

N H Alshraiedeh1, M Y Alkawareek, S P Gorman, W G Graham, B F Gilmore.   

Abstract

AIMS: The main aim of this study was to determine the virucidal inactivation efficacy of an in-house-designed atmospheric pressure, nonthermal plasma jet operated at varying helium/oxygen feed gas concentrations against MS2 bacteriophage, widely employed as a convenient surrogate for human norovirus. METHODS AND
RESULTS: The effect of variation of percentage oxygen concentration in the helium (He) carrier gas was studied and found to positively correlate with MS2 inactivation rate, indicating a role for reactive oxygen species (ROS) in viral inactivation. The inactivation rate constant increased with increasing oxygen concentrations up to 0·75% O2 . 3 log10 (99·9%) reductions in MS2 viability were achieved after 3 min of exposure to the plasma source operated in a helium/oxygen (99·25% : 0·75%) gas mixture, with >7 log10 reduction after 9 min exposure.
CONCLUSIONS: Atmospheric pressure, nonthermal plasmas may have utility in the rapid disinfection of virally contaminated surfaces for infection control applications. SIGNIFICANCE AND IMPACT OF STUDY: The atmospheric pressure, nonthermal plasma jet employed in this study exhibits rapid virucidal activity against a norovirus surrogate virus, the MS2 bacteriophage, which is superior to previously published inactivation rates for chemical disinfectants.
© 2013 The Society for Applied Microbiology.

Entities:  

Keywords:  MS2 bacteriophage; atmospheric pressure plasma; disinfection; nonthermal plasma; norovirus; plasma sterilization

Year:  2013        PMID: 23957472     DOI: 10.1111/jam.12331

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  9 in total

1.  Protective Effect of the Golden Staphyloxanthin Biosynthesis Pathway on Staphylococcus aureus under Cold Atmospheric Plasma Treatment.

Authors:  Yi Yang; Hao Wang; Huyue Zhou; Zhen Hu; Weilong Shang; Yifan Rao; Huagang Peng; Ying Zheng; Qiwen Hu; Rong Zhang; Haiyun Luo; Xiancai Rao
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

2.  Aqueous Plasma Pharmacy: Preparation Methods, Chemistry, and Therapeutic Applications.

Authors:  Jessica M Joslin; James R McCall; Justin P Bzdek; Derek C Johnson; Brooks M Hybertson
Journal:  Plasma Med       Date:  2016

3.  MS2 virus inactivation by atmospheric-pressure cold plasma using different gas carriers and power levels.

Authors:  Yan Wu; Yongdong Liang; Kai Wei; Wei Li; Maosheng Yao; Jue Zhang; Sergey A Grinshpun
Journal:  Appl Environ Microbiol       Date:  2014-11-21       Impact factor: 4.792

4.  Innovative Cold Atmospheric Plasma (iCAP) Decreases Mucopurulent Corneal Ulcer Formation and Edema and Reduces Bacterial Load in Pseudomonas Keratitis.

Authors:  Wahaj Saleem; Angela H Benton; Mary E Marquart; Shuli Wang; Waqas Saleem; Randy Vigil; Bo Huang; Anjal C Sharma
Journal:  Clin Plasma Med       Date:  2019-12-27

5.  Pseudomonas aeruginosa Biofilm Response and Resistance to Cold Atmospheric Pressure Plasma Is Linked to the Redox-Active Molecule Phenazine.

Authors:  Anne Mai-Prochnow; Mark Bradbury; Kostya Ostrikov; Anthony B Murphy
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 6.  Disinfection and Sterilization Using Plasma Technology: Fundamentals and Future Perspectives for Biological Applications.

Authors:  Akikazu Sakudo; Yoshihito Yagyu; Takashi Onodera
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

Review 7.  Nonthermal plasma as part of a novel strategy for vaccination.

Authors:  Hager Mohamed; Rita A Esposito; Michele A Kutzler; Brian Wigdahl; Fred C Krebs; Vandana Miller
Journal:  Plasma Process Polym       Date:  2020-07-13       Impact factor: 3.877

Review 8.  Review on inactivation of airborne viruses using non-thermal plasma technologies: from MS2 to coronavirus.

Authors:  Imen Assadi; Ahlem Guesmi; Oussama Baaloudj; Hichem Zeghioud; Walid Elfalleh; Naoufel Benhammadi; Lotfi Khezami; Aymen Amine Assadi
Journal:  Environ Sci Pollut Res Int       Date:  2021-11-18       Impact factor: 5.190

9.  Inactivation Efficacy of Nonthermal Plasma-Activated Solutions against Newcastle Disease Virus.

Authors:  Xia Su; Ying Tian; Hongzhuan Zhou; Yinglong Li; Zhenhua Zhang; Beiyu Jiang; Bing Yang; Jue Zhang; Jing Fang
Journal:  Appl Environ Microbiol       Date:  2018-04-16       Impact factor: 4.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.